Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
ATF6 Sustains Retinal Organoid Brush Border (Photoreceptor Inner/Outer Segments) Structural Integrity
Author Affiliations & Notes
  • Soyeon Park
    VA Palo Alto Health Care System, Palo Alto, California, United States
    Stanford University, Stanford, California, United States
  • Hyejung Min
    VA Palo Alto Health Care System, Palo Alto, California, United States
    Stanford University, Stanford, California, United States
  • Allyssa Bradley
    VA Palo Alto Health Care System, Palo Alto, California, United States
    Stanford University, Stanford, California, United States
  • Eun-Jin Lee
    VA Palo Alto Health Care System, Palo Alto, California, United States
    Stanford University, Stanford, California, United States
  • Jonathan Lin
    VA Palo Alto Health Care System, Palo Alto, California, United States
    Stanford University, Stanford, California, United States
  • Footnotes
    Commercial Relationships   Soyeon Park None; Hyejung Min None; Allyssa Bradley None; Eun-Jin Lee None; Jonathan Lin None
  • Footnotes
    Support  NIH award P30EY026877, R01NS088485; VA Merit I01BX002284, I01RX002340
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4511. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Soyeon Park, Hyejung Min, Allyssa Bradley, Eun-Jin Lee, Jonathan Lin; ATF6 Sustains Retinal Organoid Brush Border (Photoreceptor Inner/Outer Segments) Structural Integrity. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4511.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Activating transcription factor 6 (ATF6), essential in the unfolded protein response (UPR) and endoplasmic reticulum (ER) function, is linked to achromatopsia (ACHM), a hereditary cone dystrophy. Retinal organoids (RO) developed from ACHM patients reveal that loss of ATF6 leads to severe morphologic and molecular defects in cones, and increased ER stress in cones and Müller cells. Small molecule proteostasis modulators have been discovered that specifically activate or inhibit ATF6 and related UPR and ER stress regulators. We used these small molecule proteostasis modulators to chemically interrogate the role of UPR and ATF6 in developing photoreceptors in ROs.

Methods : We developed ROs from wild type human embryonic stem cells. We supplemented small molecule ATF6 inhibitor Ceapin-A7 (CA7) or ATF6 activator AA147 to ROs at different ages: Day 230 (D230), followed by analysis after 28 and 56 days; or D35 followed by analysis at D100, D150, and D230. The morphology of photoreceptor cells in growing live ROs was examined through surface-scanning imaging, while the structure of all retinal cells was studied using confocal immunofluorescent microscopy in sectioned ROs. RNA-Seq was performed on ROs, and significant gene expression changes were identified in absence of ATF6.

Results : Live imaging revealed stunting of the brush border (photoreceptor IS/OS projections) on RO surfaces with CA7 treatment. Fluorescent miroscopy cross-sections of these ROs showed shorter and fewer IS/OS from photoreceptors in CA7-treated ROs. However, no differences in TUNEL staining was seen with CA7 treatment. RNA-Seq revealed significant disruption of retinal and photoreceptor structural integrity genes in ROs lacking ATF6 function.

Conclusions : We demonstrate that chemical inhibition of ATF6 disrupts RO brush border integrity, similar to the phenotype we previously reported in ATF6 ACHM ROs, with severe stunting of photoreceptor IS/OS in the absence of photoreceptor cell death. We identify transcriptional defects in many retinal and photoreceptor structural integrity genes in absence of ATF6. Based on this, we propose that photoreceptors cannot extend or sustain their IS/OS without ATF6, therefore causing the visual deficits in patients carrying these alleles.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×